Also, because of the effect of insulin to suppress production of arterial ketone bodies [7], it is possible that stimulation of ketone body production resulting from inhibition of insulin secretion in patients treated with dialysate containing 125 mg/dL glucose might differ between those with type 2 diabetes mellitus (T2DM) and non-DM HD patients. This evidence concerns the gene INS and type 2 diabetes mellitus.